BASSANELLI, MARIA
BASSANELLI, MARIA
DIPARTIMENTO DI SCIENZE MEDICO-CHIRURGICHE E DI MEDICINA TRASLAZIONALE
[Pharmacogenomics and chemotherapy]
2010 Paris, Ida; Cappellini, Gian Carlo Antonini; Malaguti, Paola; Bassanelli, Maria; Marchetti, Paolo
A 17-gene expression signature for early identification of poor prognosis in clear cell renal cell carcinoma
2022 Bassanelli, M.; Borro, M.; Roberto, M.; Giannarelli, D.; Giacinti, S.; Di Martino, S.; Ceribelli, A.; Russo, A.; Aschelter, A.; Scarpino, S.; Montori, A.; Pescarmona, E.; Tomao, S.; Simmaco, M.; Cognetti, F.; Milella, M.; Marchetti, P.
Castration resistance prostate cancer. what is in the pipeline?
2018 DE Nunzio, Cosimo; Presicce, Fabrizio; Giacinti, Silvana; Bassanelli, Maria; Tubaro, Andrea
Clinical Outcome of Third-Line Pazopanib in a Patient with Metastatic Renal Cell Carcinoma
2015 Roberto, Michela; Bassanelli, Maria; Iannicelli, Elsa; Giacinti, Silvana; D'Antonio, Chiara; Aschelter, Anna Maria; Marchetti, Paolo
Complete response in advanced breast cancer patient treated with a combination of capecitabine, oral vinorelbine and dasatinib
2018 Sgroi, V.; Bassanelli, M.; Roberto, M.; Iannicelli, E.; Porrini, R.; Pellegrini, P.; Tafuri, A.; Marchetti, P.
Esophageal stenosis: a differential diagnosis between esophageal cancer and metastasis from other neoplasia
2014 Paris, Ida; Prelaj, Arsela; Onesti, CONCETTA ELISA; Baldoni, Alessandra; Giovagnoli, Maria Rosaria; Bassanelli, Maria; Lauro, Salvatore; Marchetti, Paolo
Evaluation of 5-fluorouracil degradation rate and pharmacogenetic profiling to predict toxicity following adjuvant capecitabine
2017 Roberto, Michela; Romiti, Adriana; Botticelli, Andrea; Mazzuca, Federica; Lionetto, Luana; Gentile, Giovanna; Paris, Ida; Falcone, Rosa; Bassanelli, Maria; DI PIETRO, FRANCESCA ROMANA; Onesti, CONCETTA ELISA; Anselmi, Elisabetta; Macrini, Serena; Simmaco, Maurizio; Marchetti, Paolo
Heterogeneity of PD-L1 expression and relationship with biology of NSCLC
2018 Bassanelli, Maria; Sioletic, Stefano; Martini, Maurizio; Giacinti, Silvana; Viterbo, Antonella; Staddon, Anita; Liberati, Fabrizio; Ceribelli, Anna
Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with nivolumab: long-term outcomes from a multi-institutional analysis
2018 Ricciuti, Biagio; Genova, Carlo; De Giglio, Andrea; Bassanelli, Maria; Dal Bello, Maria Giovanna; Metro, Giulio; Brambilla, Marta; Baglivo, Sara; Grossi, Francesco; Chiari, Rita
Molecular basis of drug resistance and insights for new treatment approaches in mCRPC
2018 Giacinti, Silvana; Poti, Giulia; Roberto, Michela; Macrini, Serena; Bassanelli, Maria; Di Pietro, Francesca; Aschelter, Anna Maria; Ceribelli, Anna; Ruggeri, Enzo Maria; Marchetti, Paolo
Multimodality treatment of brain metastases from renal cell carcinoma in the era of targeted therapy
2016 Bassanelli, Maria; Viterbo, Antonella; Roberto, Michela; Giacinti, Silvana; Staddon, Anita; Aschelter, Anna Maria; D'Antonio, Chiara; Marchetti, Paolo
Pharmacogenomics in lung cancer chemotherapy: a review of what the oncologist should know.
2014 Milano, Annalisa; Falcone, Rosa; Paris, I.; Lauro, Salvatore; Marchetti, Paolo; D'Antonio, Chiara; Righini, Riccardo; Onesti, CONCETTA ELISA; Bassanelli, Maria
Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations. Differential Effectiveness by Risk Group?
2024 Santoni, Matteo; Buti, Sebastiano; Myint, Zin W.; Maruzzo, Marco; Iacovelli, Roberto; Pichler, Martin; Kopecky, Jindrich; Kucharz, Jakub; Rizzo, Mimma; Galli, Luca; Büttner, Thomas; De Giorgi, Ugo; Kanesvaran, Ravindran; Fiala, Ondřej; Grande, Enrique; Zucali, Paolo Andrea; Kopp, Ray Manneh; Fornarini, Giuseppe; Bourlon, Maria T.; Scagliarini, Sarah; Molina-Cerrillo, Javier; Aurilio, Gaetano; Matrana, Marc R.; Pichler, Renate; Cattrini, Carlo; Büchler, Tomas; Massari, Francesco; Seront, Emmanuel; Calabrò, Fabio; Pinto, Alvaro; Berardi, Rossana; Zgura, Anca; Mammone, Giulia; Ansari, Jawaher; Atzori, Francesco; Chiari, Rita; Bamias, Aristotelis; Caffo, Orazio; Procopio, Giuseppe; Sunela, Kaisa; Bassanelli, Maria; Ortega, Cinzia; Grillone, Francesco; Landmesser, Johannes; Milella, Michele; Messina, Carlo; Küronya, Zsófia; Mosca, Alessandra; Bhuva, Dipen; Santini, Daniele; Vau, Nuno; Morelli, Franco; Incorvaia, Lorena; Rebuzzi, Sara Elena; Roviello, Giandomenico; Soares, Andrey; Bisonni, Renato; Bimbatti, Davide; Zabalza, Ignacio Ortego; Rizzo, Alessandro; Mollica, Veronica; Sorgentoni, Giulia; Monteiro, Fernando Sabino M.; Battelli, Nicola; Bracarda, Sergio; Porta, Camillo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| [Pharmacogenomics and chemotherapy] | 2010 | Paris, Ida; Cappellini, Gian Carlo Antonini; Malaguti, Paola; Bassanelli, Maria; Marchetti, Paolo | |
| A 17-gene expression signature for early identification of poor prognosis in clear cell renal cell carcinoma | 2022 | Bassanelli, M.; Borro, M.; Roberto, M.; Giannarelli, D.; Giacinti, S.; Di Martino, S.; Ceribelli, A.; Russo, A.; Aschelter, A.; Scarpino, S.; Montori, A.; Pescarmona, E.; Tomao, S.; Simmaco, M.; Cognetti, F.; Milella, M.; Marchetti, P. | |
| Castration resistance prostate cancer. what is in the pipeline? | 2018 | DE Nunzio, Cosimo; Presicce, Fabrizio; Giacinti, Silvana; Bassanelli, Maria; Tubaro, Andrea | |
| Clinical Outcome of Third-Line Pazopanib in a Patient with Metastatic Renal Cell Carcinoma | 2015 | Roberto, Michela; Bassanelli, Maria; Iannicelli, Elsa; Giacinti, Silvana; D'Antonio, Chiara; Aschelter, Anna Maria; Marchetti, Paolo | |
| Complete response in advanced breast cancer patient treated with a combination of capecitabine, oral vinorelbine and dasatinib | 2018 | Sgroi, V.; Bassanelli, M.; Roberto, M.; Iannicelli, E.; Porrini, R.; Pellegrini, P.; Tafuri, A.; Marchetti, P. | |
| Esophageal stenosis: a differential diagnosis between esophageal cancer and metastasis from other neoplasia | 2014 | Paris, Ida; Prelaj, Arsela; Onesti, CONCETTA ELISA; Baldoni, Alessandra; Giovagnoli, Maria Rosaria; Bassanelli, Maria; Lauro, Salvatore; Marchetti, Paolo | |
| Evaluation of 5-fluorouracil degradation rate and pharmacogenetic profiling to predict toxicity following adjuvant capecitabine | 2017 | Roberto, Michela; Romiti, Adriana; Botticelli, Andrea; Mazzuca, Federica; Lionetto, Luana; Gentile, Giovanna; Paris, Ida; Falcone, Rosa; Bassanelli, Maria; DI PIETRO, FRANCESCA ROMANA; Onesti, CONCETTA ELISA; Anselmi, Elisabetta; Macrini, Serena; Simmaco, Maurizio; Marchetti, Paolo | |
| Heterogeneity of PD-L1 expression and relationship with biology of NSCLC | 2018 | Bassanelli, Maria; Sioletic, Stefano; Martini, Maurizio; Giacinti, Silvana; Viterbo, Antonella; Staddon, Anita; Liberati, Fabrizio; Ceribelli, Anna | |
| Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with nivolumab: long-term outcomes from a multi-institutional analysis | 2018 | Ricciuti, Biagio; Genova, Carlo; De Giglio, Andrea; Bassanelli, Maria; Dal Bello, Maria Giovanna; Metro, Giulio; Brambilla, Marta; Baglivo, Sara; Grossi, Francesco; Chiari, Rita | |
| Molecular basis of drug resistance and insights for new treatment approaches in mCRPC | 2018 | Giacinti, Silvana; Poti, Giulia; Roberto, Michela; Macrini, Serena; Bassanelli, Maria; Di Pietro, Francesca; Aschelter, Anna Maria; Ceribelli, Anna; Ruggeri, Enzo Maria; Marchetti, Paolo | |
| Multimodality treatment of brain metastases from renal cell carcinoma in the era of targeted therapy | 2016 | Bassanelli, Maria; Viterbo, Antonella; Roberto, Michela; Giacinti, Silvana; Staddon, Anita; Aschelter, Anna Maria; D'Antonio, Chiara; Marchetti, Paolo | |
| Pharmacogenomics in lung cancer chemotherapy: a review of what the oncologist should know. | 2014 | Milano, Annalisa; Falcone, Rosa; Paris, I.; Lauro, Salvatore; Marchetti, Paolo; D'Antonio, Chiara; Righini, Riccardo; Onesti, CONCETTA ELISA; Bassanelli, Maria | |
| Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations. Differential Effectiveness by Risk Group? | 2024 | Santoni, Matteo; Buti, Sebastiano; Myint, Zin W.; Maruzzo, Marco; Iacovelli, Roberto; Pichler, Martin; Kopecky, Jindrich; Kucharz, Jakub; Rizzo, Mimma; Galli, Luca; Büttner, Thomas; De Giorgi, Ugo; Kanesvaran, Ravindran; Fiala, Ondřej; Grande, Enrique; Zucali, Paolo Andrea; Kopp, Ray Manneh; Fornarini, Giuseppe; Bourlon, Maria T.; Scagliarini, Sarah; Molina-Cerrillo, Javier; Aurilio, Gaetano; Matrana, Marc R.; Pichler, Renate; Cattrini, Carlo; Büchler, Tomas; Massari, Francesco; Seront, Emmanuel; Calabrò, Fabio; Pinto, Alvaro; Berardi, Rossana; Zgura, Anca; Mammone, Giulia; Ansari, Jawaher; Atzori, Francesco; Chiari, Rita; Bamias, Aristotelis; Caffo, Orazio; Procopio, Giuseppe; Sunela, Kaisa; Bassanelli, Maria; Ortega, Cinzia; Grillone, Francesco; Landmesser, Johannes; Milella, Michele; Messina, Carlo; Küronya, Zsófia; Mosca, Alessandra; Bhuva, Dipen; Santini, Daniele; Vau, Nuno; Morelli, Franco; Incorvaia, Lorena; Rebuzzi, Sara Elena; Roviello, Giandomenico; Soares, Andrey; Bisonni, Renato; Bimbatti, Davide; Zabalza, Ignacio Ortego; Rizzo, Alessandro; Mollica, Veronica; Sorgentoni, Giulia; Monteiro, Fernando Sabino M.; Battelli, Nicola; Bracarda, Sergio; Porta, Camillo |